Clinical Trial Update: Combination Therapy of Hydroxyurea With L-Carnitine and Magnesium Chloride in Thalassemia Intermedia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a combination of hydroxyurea, L-carnitine, and magnesium chloride for beta-thalassemia intermedia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia Intermedia

Drugs mentioned

• HYDROXYUREA (Hydroxyurea)
• L-carnitine (L-carnitine)
• Magnesium chloride (Magnesium chloride)

Snippet

Sponsor: Shiraz University of Medical Sciences | Conditions: β-Thalassemia Intermedia | Phase 2 | Status: COMPLETED